| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2003 | 2013 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2005 | 2013 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 1997 | 2005 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2005 | 2009 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2003 | 2010 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2006 | 2010 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2007 | 2008 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2006 | 2011 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2005 | 2017 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2005 | 2009 | ||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2006 | 2010 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2017 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2005 | 2012 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2006 | 2008 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2017 | ||||||||
|
DNA methyltransferase 3 beta | 0.453 | 0.846 | 0.20 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2012 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2011 | ||||||||
|
vascular endothelial growth factor C | 0.459 | 0.769 | 0.50 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2015 | ||||||||
|
breast cancer anti-estrogen resistance 4 | 0.653 | 0.346 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2011 | |||||||||
|
uridine monophosphate synthetase | 0.584 | 0.615 | 1.1E-04 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
zinc finger E-box binding homeobox 1 | 0.442 | 0.808 | 0.97 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2011 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2011 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2011 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2009 | ||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2018 | 2018 |